Yves Van der Stede

Yves Van der Stede

Auto-generated profile, based on publicly available information

Yves Van der Stede

European Food Safety Authority, Parma, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in EFSA Journal
Verified
Journal Article
Open access
PDF file
EPEFSA Panel on Animal Health and Welfare (EFSA AHAW Panel)
EFSA Panel on Animal Health and Welfare (EFSA AHAW Panel)
SNSøren Nielsen
Søren Nielsen
JAJulio Alvarez
Julio Alvarez
DBDominique Joseph Bicout
Dominique Joseph Bicout
PCPaolo Calistri
Paolo Calistri
IAInma Aznar
Inma Aznar
EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429...

11 September 2012 in Statistical Modelling
Verified
Journal Article
Closed access
KBK Bollaerts
K Bollaerts
MAM Aerts
M Aerts
ZSZ Shkedy
Z Shkedy
CFChristel Faes
Christel Faes
YSY Van der Stede
Y Van der Stede
NHN Hens
N Hens
The use of threshold values in order to diagnose individual subjects as being ‘susceptible’ or ‘infected or recovered/immune’ for a specific infection is virtually always prone to false positive, false negative or inconclusive classifications. Such misclassifications might lead to biased estimates for epidemiological parameters, such as the prevalence and the force of infection. In this article, we propose to estimate these epidemiological parameters directly from antibody titres, using an underlying mixture model. The method is applied to estimate the Salmonella serological prevalence in pigs and the age-dependent force of infection using serological data on the Varicella-Zoster virus (VZV) in humans. The threshold and direct method are compared through a simulation study.

14 October 2021 in Eurosurveillance
Verified
Journal Article
Open access
IBIdesbald Boone
Idesbald Boone
BRBettina Rosner
Bettina Rosner
RLRaskit Lachmann
Raskit Lachmann
MDMichele Luca D'Errico
Michele Luca D'Errico
LILuigi Iannetti
Luigi Iannetti
HWHendrik Wilking
Hendrik Wilking
Background: Healthcare-associated foodborne outbreaks (HA-FBO) may have severe consequences, especially in vulnerable groups.Aim: The aim was to describe the current state of HA-FBO and propose public health recommendations for prevention.Methods: We searched PubMed, the Outbreak Database (Charité, University Medicine Berlin), and hand-searched reference lists for HA-FBO with outbreak onset between 2001 and 2018 from Organisation for Economic Co-operation and Development (OECD) countries and HA-FBO (2012–2018) from the German surveillance system. Additionally, data from the European Food Safety Authority were analysed.Results: The literature search retrieved 57 HA-FBO from 16 OECD countries, primarily in the US (n = 11), Germany (n = 11) and the United Kingdom (n = 9). In addition, 28 HA-FBO were retrieved from the German surveillance system. Based on the number of outbreaks, the top three pathogens associated with the overall 85 HA-FBO wereSalmonella(n = 24), norovirus (n = 22) andListeria monocytogenes(n = 19). Based on the number of deaths,L. monocytogeneswas the main pathogen causing HA-FBO. Frequently reported implicated foods were ‘mixed foods’ (n = 16), ‘vegetables and fruits’ (n = 15) and ‘meat and meat products’ (n = 10). Consumption of high-risk food by vulnerable patients, inadequate time-temperature control, insufficient kitchen hygiene and food hygiene and carriers of pathogens among food handlers were reported as reasons for HA-FBO.Conclusion: To prevent HA-FBO, the supply of high-risk food to vulnerable people should be avoided. Well working outbreak surveillance facilitates early detection and requires close interdisciplinary collaboration and exchange of information between hospitals, food safety and public health authorities.

1 April 2010 in Journal of Virological Methods
Verified
Journal Article
Closed access
EVElise Vandemeulebroucke
Elise Vandemeulebroucke
KCKris De Clercq
Kris De Clercq
YSYves Van der Stede
Yves Van der Stede
FVFrank Vandenbussche
Frank Vandenbussche

26 September 2016 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
PDF file
SWS. Welby
S. Welby
GSGerdien van Schaik
Gerdien van Schaik
AVA. Veldhuis
A. Veldhuis
HBH. Brouwer-Middelesch
H. Brouwer-Middelesch
CPC. Peroz
C. Peroz
YSY. Van der Stede
Y. Van der Stede
Quick detection and recovery of country's freedom status remain a constant challenge in animal health surveillance. The efficacy and cost efficiency of different surveillance components in proving the absence of infection or (early) detection of bluetongue serotype 8 in cattle populations within different countries (the Netherlands, France, Belgium) using surveillance data from years 2006 and 2007 were investigated using an adapted scenario tree model approach. First, surveillance components (sentinel, yearly cross‐sectional and passive clinical reporting) within each country were evaluated in terms of efficacy for substantiating freedom of infection. Yearly cross‐sectional survey and passive clinical reporting performed well within each country with sensitivity of detection values ranging around 0.99. The sentinel component had a sensitivity of detection around 0.7. Secondly, how effective the components were for (early) detection of bluetongue serotype 8 and whether syndromic surveillance on reproductive performance, milk production and mortality data available from the Netherlands and Belgium could be of added value were evaluated. Epidemic curves were used to estimate the timeliness of detection. Sensitivity analysis revealed that expected within‐herd prevalence and number of herds processed were the most influential parameters for proving freedom and early detection. Looking at the assumed direct costs, although total costs were low for sentinel and passive clinical surveillance components, passive clinical surveillance together with syndromic surveillance (based on reproductive performance data) turned out most cost‐efficient for the detection of bluetongue serotype 8. To conclude, for emerging or re‐emerging vectorborne disease that behaves such as bluetongue serotype 8, it is recommended to use passive clinical and syndromic surveillance as early detection systems for maximum cost efficiency and sensitivity. Once an infection is detected and eradicated, cross‐sectional screening for substantiating freedom of infection and sentinel for monitoring the disease evolution are recommended.